Lidamycin decreases CD133 expression in hepatocellular carcinoma via the Notch signaling pathway

Cluster of differentiation (CD)133 is considered a molecular marker of cancer stem cells in hepatocellular carcinoma. In the present study, the effect of lidamycin (LDM) on CD133 expression in hepatocellular carcinoma (Huh7 cells) was evaluated and the potential molecular mechanism was investigated....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: Chen, Yi, Sun, Wenwei, He, Ran, Zhang, Feiyan, Wang, Hongyu, Li, Panhong, Shao, Rong-Guang, Xu, Xiaoyu
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2017
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5755037/
https://ncbi.nlm.nih.gov/pubmed/29344233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7248
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi